カテゴリー： LP Information, 世界, 部品/材料

世界の医薬品有効成分（API）市場予測 2023年-2029年

◆英語タイトル：Global Active Pharmaceutical Ingredient (API) Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU1178）◆商品コード：LP23JU1178
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：122
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の医薬品有効成分（API）市場」は、過去の販売実績から2022年の世界の医薬品有効成分（API）の総販売量を検討し、2023年から2029年の予測される医薬品有効成分（API）の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医薬品有効成分（API）の市場規模を掲載し、XXX百万米ドル規模の世界の医薬品有効成分（API）市場の詳細な分析を提供します。本インサイトレポートは、世界の医薬品有効成分（API）業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の医薬品有効成分（API）市場における各社の独自のポジションをより深く理解するために、医薬品有効成分（API）製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の医薬品有効成分（API）市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医薬品有効成分（API）の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。医薬品有効成分（API）の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医薬品有効成分（API）のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

医薬品有効成分（API）の世界主要メーカーとしては、Teva、 Mylan、 DSM、 Aurobindo Pharma、 Aspen、 Novartis、 BASF、 Pfizer、 Huahai Pharmaceutical、 Hisun Pharmaceutical、 Sun Pharmaceutical Industries、 Zhejiang Medicine、 Dr. Reddy’s Laboratories、 Zhejiang NHU、 Bayer、 NCPC、 AbbVie、 Shandong Xinhua Pharmaceutical、 Northeast Pharm、 Harbin Pharmaceutical、 LKPCなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の医薬品有効成分（API）市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では医薬品有効成分（API）市場をセグメンテーションし、種類別 (抗感染症、ホルモン、その他)、用途別 (呼吸器科、リウマチ科、糖尿病科、腫瘍科、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：抗感染症、ホルモン、その他

・用途別区分：呼吸器科、リウマチ科、糖尿病科、腫瘍科、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の医薬品有効成分（API）市場の10年間の市場状況・展望は？
・世界および地域別に見た医薬品有効成分（API）市場成長の要因は何か？
・医薬品有効成分（API）の市場機会はエンドマーケットの規模によってどのように変化するのか？
・医薬品有効成分（API）のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：医薬品有効成分（API）の年間販売量2018-2029、地域別現状・将来分析
・医薬品有効成分（API）の種類別セグメント：抗感染症、ホルモン、その他
・医薬品有効成分（API）の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・医薬品有効成分（API）の用途別セグメント：呼吸器科、リウマチ科、糖尿病科、腫瘍科、その他
・医薬品有効成分（API）の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の医薬品有効成分（API）市場
・企業別のグローバル医薬品有効成分（API）市場データ：2018-2023年の年間販売量、市場シェア
・企業別の医薬品有効成分（API）の年間売上：2018-2023年の売上、市場シェア
・企業別の医薬品有効成分（API）販売価格
・主要企業の医薬品有効成分（API）生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

医薬品有効成分（API）の地域別レビュー
・地域別の医薬品有効成分（API）市場規模2018-2023：年間販売量、売上
・主要国別の医薬品有効成分（API）市場規模2018-2023：年間販売量、売上
・南北アメリカの医薬品有効成分（API）販売の成長
・アジア太平洋の医薬品有効成分（API）販売の成長
・ヨーロッパの医薬品有効成分（API）販売の成長
・中東・アフリカの医薬品有効成分（API）販売の成長

南北アメリカ市場
・南北アメリカの国別の医薬品有効成分（API）販売量、売上（2018-2023）
・南北アメリカの医薬品有効成分（API）の種類別販売量
・南北アメリカの医薬品有効成分（API）の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の医薬品有効成分（API）販売量、売上（2018-2023）
・アジア太平洋の医薬品有効成分（API）の種類別販売量
・アジア太平洋の医薬品有効成分（API）の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の医薬品有効成分（API）販売量、売上（2018-2023）
・ヨーロッパの医薬品有効成分（API）の種類別販売量
・ヨーロッパの医薬品有効成分（API）の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の医薬品有効成分（API）販売量、売上（2018-2023）
・中東・アフリカの医薬品有効成分（API）の種類別販売量
・中東・アフリカの医薬品有効成分（API）の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・医薬品有効成分（API）の製造コスト構造分析
・医薬品有効成分（API）の製造プロセス分析
・医薬品有効成分（API）の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・医薬品有効成分（API）の主要なグローバル販売業者
・医薬品有効成分（API）の主要なグローバル顧客

地域別の医薬品有効成分（API）市場予測レビュー
・地域別の医薬品有効成分（API）市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・医薬品有効成分（API）の種類別市場規模予測
・医薬品有効成分（API）の用途別市場規模予測

主要企業分析
Teva、 Mylan、 DSM、 Aurobindo Pharma、 Aspen、 Novartis、 BASF、 Pfizer、 Huahai Pharmaceutical、 Hisun Pharmaceutical、 Sun Pharmaceutical Industries、 Zhejiang Medicine、 Dr. Reddy’s Laboratories、 Zhejiang NHU、 Bayer、 NCPC、 AbbVie、 Shandong Xinhua Pharmaceutical、 Northeast Pharm、 Harbin Pharmaceutical、 LKPC
・企業情報
・医薬品有効成分（API）製品
・医薬品有効成分（API）販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
LPI (LP Information)’ newest research report, the “Active Pharmaceutical Ingredient (API) Industry Forecast” looks at past sales and reviews total world Active Pharmaceutical Ingredient (API) sales in 2022, providing a comprehensive analysis by region and market sector of projected Active Pharmaceutical Ingredient (API) sales for 2023 through 2029. With Active Pharmaceutical Ingredient (API) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Active Pharmaceutical Ingredient (API) industry.
This Insight Report provides a comprehensive analysis of the global Active Pharmaceutical Ingredient (API) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Active Pharmaceutical Ingredient (API) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Active Pharmaceutical Ingredient (API) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Active Pharmaceutical Ingredient (API) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Active Pharmaceutical Ingredient (API).
The global Active Pharmaceutical Ingredient (API) market size is projected to grow from US$ 70520 million in 2022 to US$ 112110 million in 2029; it is expected to grow at a CAGR of 112110 from 2023 to 2029.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.
This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredient (API) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Anti-Infective
Hormonal
Others
Segmentation by application
Respiratory
Rheumatology
Diabetes
Oncology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Active Pharmaceutical Ingredient (API) market?
What factors are driving Active Pharmaceutical Ingredient (API) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Active Pharmaceutical Ingredient (API) market opportunities vary by end market size?
How does Active Pharmaceutical Ingredient (API) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Active Pharmaceutical Ingredient (API) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Active Pharmaceutical Ingredient (API) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Active Pharmaceutical Ingredient (API) by Country/Region, 2018, 2022 & 2029
2.2 Active Pharmaceutical Ingredient (API) Segment by Type
2.2.1 Anti-Infective
2.2.2 Hormonal
2.2.3 Others
2.3 Active Pharmaceutical Ingredient (API) Sales by Type
2.3.1 Global Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2018-2023)
2.3.2 Global Active Pharmaceutical Ingredient (API) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Active Pharmaceutical Ingredient (API) Sale Price by Type (2018-2023)
2.4 Active Pharmaceutical Ingredient (API) Segment by Application
2.4.1 Respiratory
2.4.2 Rheumatology
2.4.3 Diabetes
2.4.4 Oncology
2.4.5 Others
2.5 Active Pharmaceutical Ingredient (API) Sales by Application
2.5.1 Global Active Pharmaceutical Ingredient (API) Sale Market Share by Application (2018-2023)
2.5.2 Global Active Pharmaceutical Ingredient (API) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Active Pharmaceutical Ingredient (API) Sale Price by Application (2018-2023)
3 Global Active Pharmaceutical Ingredient (API) by Company
3.1 Global Active Pharmaceutical Ingredient (API) Breakdown Data by Company
3.1.1 Global Active Pharmaceutical Ingredient (API) Annual Sales by Company (2018-2023)
3.1.2 Global Active Pharmaceutical Ingredient (API) Sales Market Share by Company (2018-2023)
3.2 Global Active Pharmaceutical Ingredient (API) Annual Revenue by Company (2018-2023)
3.2.1 Global Active Pharmaceutical Ingredient (API) Revenue by Company (2018-2023)
3.2.2 Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Company (2018-2023)
3.3 Global Active Pharmaceutical Ingredient (API) Sale Price by Company
3.4 Key Manufacturers Active Pharmaceutical Ingredient (API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Active Pharmaceutical Ingredient (API) Product Location Distribution
3.4.2 Players Active Pharmaceutical Ingredient (API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Active Pharmaceutical Ingredient (API) by Geographic Region
4.1 World Historic Active Pharmaceutical Ingredient (API) Market Size by Geographic Region (2018-2023)
4.1.1 Global Active Pharmaceutical Ingredient (API) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Active Pharmaceutical Ingredient (API) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Active Pharmaceutical Ingredient (API) Market Size by Country/Region (2018-2023)
4.2.1 Global Active Pharmaceutical Ingredient (API) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Active Pharmaceutical Ingredient (API) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Active Pharmaceutical Ingredient (API) Sales Growth
4.4 APAC Active Pharmaceutical Ingredient (API) Sales Growth
4.5 Europe Active Pharmaceutical Ingredient (API) Sales Growth
4.6 Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Growth
5 Americas
5.1 Americas Active Pharmaceutical Ingredient (API) Sales by Country
5.1.1 Americas Active Pharmaceutical Ingredient (API) Sales by Country (2018-2023)
5.1.2 Americas Active Pharmaceutical Ingredient (API) Revenue by Country (2018-2023)
5.2 Americas Active Pharmaceutical Ingredient (API) Sales by Type
5.3 Americas Active Pharmaceutical Ingredient (API) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Active Pharmaceutical Ingredient (API) Sales by Region
6.1.1 APAC Active Pharmaceutical Ingredient (API) Sales by Region (2018-2023)
6.1.2 APAC Active Pharmaceutical Ingredient (API) Revenue by Region (2018-2023)
6.2 APAC Active Pharmaceutical Ingredient (API) Sales by Type
6.3 APAC Active Pharmaceutical Ingredient (API) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Active Pharmaceutical Ingredient (API) by Country
7.1.1 Europe Active Pharmaceutical Ingredient (API) Sales by Country (2018-2023)
7.1.2 Europe Active Pharmaceutical Ingredient (API) Revenue by Country (2018-2023)
7.2 Europe Active Pharmaceutical Ingredient (API) Sales by Type
7.3 Europe Active Pharmaceutical Ingredient (API) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Active Pharmaceutical Ingredient (API) by Country
8.1.1 Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue by Country (2018-2023)
8.2 Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Type
8.3 Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient (API)
10.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient (API)
10.4 Industry Chain Structure of Active Pharmaceutical Ingredient (API)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Active Pharmaceutical Ingredient (API) Distributors
11.3 Active Pharmaceutical Ingredient (API) Customer
12 World Forecast Review for Active Pharmaceutical Ingredient (API) by Geographic Region
12.1 Global Active Pharmaceutical Ingredient (API) Market Size Forecast by Region
12.1.1 Global Active Pharmaceutical Ingredient (API) Forecast by Region (2024-2029)
12.1.2 Global Active Pharmaceutical Ingredient (API) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Active Pharmaceutical Ingredient (API) Forecast by Type
12.7 Global Active Pharmaceutical Ingredient (API) Forecast by Application
13 Key Players Analysis
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.1.3 Teva Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.2.3 Mylan Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 DSM
13.3.1 DSM Company Information
13.3.2 DSM Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.3.3 DSM Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 DSM Main Business Overview
13.3.5 DSM Latest Developments
13.4 Aurobindo Pharma
13.4.1 Aurobindo Pharma Company Information
13.4.2 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.4.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aurobindo Pharma Main Business Overview
13.4.5 Aurobindo Pharma Latest Developments
13.5 Aspen
13.5.1 Aspen Company Information
13.5.2 Aspen Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.5.3 Aspen Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Aspen Main Business Overview
13.5.5 Aspen Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.6.3 Novartis Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 BASF
13.7.1 BASF Company Information
13.7.2 BASF Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.7.3 BASF Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 BASF Main Business Overview
13.7.5 BASF Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.8.3 Pfizer Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Huahai Pharmaceutical
13.9.1 Huahai Pharmaceutical Company Information
13.9.2 Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Huahai Pharmaceutical Main Business Overview
13.9.5 Huahai Pharmaceutical Latest Developments
13.10 Hisun Pharmaceutical
13.10.1 Hisun Pharmaceutical Company Information
13.10.2 Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hisun Pharmaceutical Main Business Overview
13.10.5 Hisun Pharmaceutical Latest Developments
13.11 Sun Pharmaceutical Industries
13.11.1 Sun Pharmaceutical Industries Company Information
13.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sun Pharmaceutical Industries Main Business Overview
13.11.5 Sun Pharmaceutical Industries Latest Developments
13.12 Zhejiang Medicine
13.12.1 Zhejiang Medicine Company Information
13.12.2 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.12.3 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zhejiang Medicine Main Business Overview
13.12.5 Zhejiang Medicine Latest Developments
13.13 Dr. Reddy’s Laboratories
13.13.1 Dr. Reddy’s Laboratories Company Information
13.13.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Dr. Reddy’s Laboratories Main Business Overview
13.13.5 Dr. Reddy’s Laboratories Latest Developments
13.14 Zhejiang NHU
13.14.1 Zhejiang NHU Company Information
13.14.2 Zhejiang NHU Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.14.3 Zhejiang NHU Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Zhejiang NHU Main Business Overview
13.14.5 Zhejiang NHU Latest Developments
13.15 Bayer
13.15.1 Bayer Company Information
13.15.2 Bayer Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.15.3 Bayer Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Bayer Main Business Overview
13.15.5 Bayer Latest Developments
13.16 NCPC
13.16.1 NCPC Company Information
13.16.2 NCPC Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.16.3 NCPC Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 NCPC Main Business Overview
13.16.5 NCPC Latest Developments
13.17 AbbVie
13.17.1 AbbVie Company Information
13.17.2 AbbVie Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.17.3 AbbVie Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 AbbVie Main Business Overview
13.17.5 AbbVie Latest Developments
13.18 Shandong Xinhua Pharmaceutical
13.18.1 Shandong Xinhua Pharmaceutical Company Information
13.18.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Shandong Xinhua Pharmaceutical Main Business Overview
13.18.5 Shandong Xinhua Pharmaceutical Latest Developments
13.19 Northeast Pharm
13.19.1 Northeast Pharm Company Information
13.19.2 Northeast Pharm Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.19.3 Northeast Pharm Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Northeast Pharm Main Business Overview
13.19.5 Northeast Pharm Latest Developments
13.20 Harbin Pharmaceutical
13.20.1 Harbin Pharmaceutical Company Information
13.20.2 Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Harbin Pharmaceutical Main Business Overview
13.20.5 Harbin Pharmaceutical Latest Developments
13.21 LKPC
13.21.1 LKPC Company Information
13.21.2 LKPC Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
13.21.3 LKPC Active Pharmaceutical Ingredient (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 LKPC Main Business Overview
13.21.5 LKPC Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Active Pharmaceutical Ingredient (API) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Active Pharmaceutical Ingredient (API) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Anti-Infective
Table 4. Major Players of Hormonal
Table 5. Major Players of Others
Table 6. Global Active Pharmaceutical Ingredient (API) Sales by Type (2018-2023) & (K MT)
Table 7. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2018-2023)
Table 8. Global Active Pharmaceutical Ingredient (API) Revenue by Type (2018-2023) & ($ million)
Table 9. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2018-2023)
Table 10. Global Active Pharmaceutical Ingredient (API) Sale Price by Type (2018-2023) & (USD/MT)
Table 11. Global Active Pharmaceutical Ingredient (API) Sales by Application (2018-2023) & (K MT)
Table 12. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2018-2023)
Table 13. Global Active Pharmaceutical Ingredient (API) Revenue by Application (2018-2023)
Table 14. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2018-2023)
Table 15. Global Active Pharmaceutical Ingredient (API) Sale Price by Application (2018-2023) & (USD/MT)
Table 16. Global Active Pharmaceutical Ingredient (API) Sales by Company (2018-2023) & (K MT)
Table 17. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Company (2018-2023)
Table 18. Global Active Pharmaceutical Ingredient (API) Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Company (2018-2023)
Table 20. Global Active Pharmaceutical Ingredient (API) Sale Price by Company (2018-2023) & (USD/MT)
Table 21. Key Manufacturers Active Pharmaceutical Ingredient (API) Producing Area Distribution and Sales Area
Table 22. Players Active Pharmaceutical Ingredient (API) Products Offered
Table 23. Active Pharmaceutical Ingredient (API) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Active Pharmaceutical Ingredient (API) Sales by Geographic Region (2018-2023) & (K MT)
Table 27. Global Active Pharmaceutical Ingredient (API) Sales Market Share Geographic Region (2018-2023)
Table 28. Global Active Pharmaceutical Ingredient (API) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Active Pharmaceutical Ingredient (API) Sales by Country/Region (2018-2023) & (K MT)
Table 31. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Country/Region (2018-2023)
Table 32. Global Active Pharmaceutical Ingredient (API) Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Active Pharmaceutical Ingredient (API) Sales by Country (2018-2023) & (K MT)
Table 35. Americas Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2018-2023)
Table 36. Americas Active Pharmaceutical Ingredient (API) Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2018-2023)
Table 38. Americas Active Pharmaceutical Ingredient (API) Sales by Type (2018-2023) & (K MT)
Table 39. Americas Active Pharmaceutical Ingredient (API) Sales by Application (2018-2023) & (K MT)
Table 40. APAC Active Pharmaceutical Ingredient (API) Sales by Region (2018-2023) & (K MT)
Table 41. APAC Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2018-2023)
Table 42. APAC Active Pharmaceutical Ingredient (API) Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2018-2023)
Table 44. APAC Active Pharmaceutical Ingredient (API) Sales by Type (2018-2023) & (K MT)
Table 45. APAC Active Pharmaceutical Ingredient (API) Sales by Application (2018-2023) & (K MT)
Table 46. Europe Active Pharmaceutical Ingredient (API) Sales by Country (2018-2023) & (K MT)
Table 47. Europe Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2018-2023)
Table 48. Europe Active Pharmaceutical Ingredient (API) Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2018-2023)
Table 50. Europe Active Pharmaceutical Ingredient (API) Sales by Type (2018-2023) & (K MT)
Table 51. Europe Active Pharmaceutical Ingredient (API) Sales by Application (2018-2023) & (K MT)
Table 52. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Country (2018-2023) & (K MT)
Table 53. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Type (2018-2023) & (K MT)
Table 57. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Application (2018-2023) & (K MT)
Table 58. Key Market Drivers & Growth Opportunities of Active Pharmaceutical Ingredient (API)
Table 59. Key Market Challenges & Risks of Active Pharmaceutical Ingredient (API)
Table 60. Key Industry Trends of Active Pharmaceutical Ingredient (API)
Table 61. Active Pharmaceutical Ingredient (API) Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Active Pharmaceutical Ingredient (API) Distributors List
Table 64. Active Pharmaceutical Ingredient (API) Customer List
Table 65. Global Active Pharmaceutical Ingredient (API) Sales Forecast by Region (2024-2029) & (K MT)
Table 66. Global Active Pharmaceutical Ingredient (API) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2024-2029) & (K MT)
Table 68. Americas Active Pharmaceutical Ingredient (API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Active Pharmaceutical Ingredient (API) Sales Forecast by Region (2024-2029) & (K MT)
Table 70. APAC Active Pharmaceutical Ingredient (API) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2024-2029) & (K MT)
Table 72. Europe Active Pharmaceutical Ingredient (API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2024-2029) & (K MT)
Table 74. Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Active Pharmaceutical Ingredient (API) Sales Forecast by Type (2024-2029) & (K MT)
Table 76. Global Active Pharmaceutical Ingredient (API) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Active Pharmaceutical Ingredient (API) Sales Forecast by Application (2024-2029) & (K MT)
Table 78. Global Active Pharmaceutical Ingredient (API) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Teva Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 81. Teva Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Mylan Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 86. Mylan Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. DSM Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 90. DSM Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 91. DSM Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. DSM Main Business
Table 93. DSM Latest Developments
Table 94. Aurobindo Pharma Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 95. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 96. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Aurobindo Pharma Main Business
Table 98. Aurobindo Pharma Latest Developments
Table 99. Aspen Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 100. Aspen Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 101. Aspen Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Aspen Main Business
Table 103. Aspen Latest Developments
Table 104. Novartis Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 105. Novartis Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 106. Novartis Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Novartis Main Business
Table 108. Novartis Latest Developments
Table 109. BASF Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 110. BASF Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 111. BASF Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. BASF Main Business
Table 113. BASF Latest Developments
Table 114. Pfizer Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 115. Pfizer Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 116. Pfizer Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Pfizer Main Business
Table 118. Pfizer Latest Developments
Table 119. Huahai Pharmaceutical Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 120. Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 121. Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Huahai Pharmaceutical Main Business
Table 123. Huahai Pharmaceutical Latest Developments
Table 124. Hisun Pharmaceutical Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 125. Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 126. Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Hisun Pharmaceutical Main Business
Table 128. Hisun Pharmaceutical Latest Developments
Table 129. Sun Pharmaceutical Industries Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 130. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 131. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. Sun Pharmaceutical Industries Main Business
Table 133. Sun Pharmaceutical Industries Latest Developments
Table 134. Zhejiang Medicine Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 135. Zhejiang Medicine Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 136. Zhejiang Medicine Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 137. Zhejiang Medicine Main Business
Table 138. Zhejiang Medicine Latest Developments
Table 139. Dr. Reddy’s Laboratories Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 140. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 141. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 142. Dr. Reddy’s Laboratories Main Business
Table 143. Dr. Reddy’s Laboratories Latest Developments
Table 144. Zhejiang NHU Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 145. Zhejiang NHU Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 146. Zhejiang NHU Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 147. Zhejiang NHU Main Business
Table 148. Zhejiang NHU Latest Developments
Table 149. Bayer Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 150. Bayer Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 151. Bayer Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 152. Bayer Main Business
Table 153. Bayer Latest Developments
Table 154. NCPC Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 155. NCPC Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 156. NCPC Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 157. NCPC Main Business
Table 158. NCPC Latest Developments
Table 159. AbbVie Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 160. AbbVie Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 161. AbbVie Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 162. AbbVie Main Business
Table 163. AbbVie Latest Developments
Table 164. Shandong Xinhua Pharmaceutical Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 165. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 166. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 167. Shandong Xinhua Pharmaceutical Main Business
Table 168. Shandong Xinhua Pharmaceutical Latest Developments
Table 169. Northeast Pharm Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 170. Northeast Pharm Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 171. Northeast Pharm Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 172. Northeast Pharm Main Business
Table 173. Northeast Pharm Latest Developments
Table 174. Harbin Pharmaceutical Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 175. Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 176. Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 177. Harbin Pharmaceutical Main Business
Table 178. Harbin Pharmaceutical Latest Developments
Table 179. LKPC Basic Information, Active Pharmaceutical Ingredient (API) Manufacturing Base, Sales Area and Its Competitors
Table 180. LKPC Active Pharmaceutical Ingredient (API) Product Portfolios and Specifications
Table 181. LKPC Active Pharmaceutical Ingredient (API) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 182. LKPC Main Business
Table 183. LKPC Latest Developments
List of Figures
Figure 1. Picture of Active Pharmaceutical Ingredient (API)
Figure 2. Active Pharmaceutical Ingredient (API) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Active Pharmaceutical Ingredient (API) Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Active Pharmaceutical Ingredient (API) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Active Pharmaceutical Ingredient (API) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Anti-Infective
Figure 10. Product Picture of Hormonal
Figure 11. Product Picture of Others
Figure 12. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Type in 2022
Figure 13. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2018-2023)
Figure 14. Active Pharmaceutical Ingredient (API) Consumed in Respiratory
Figure 15. Global Active Pharmaceutical Ingredient (API) Market: Respiratory (2018-2023) & (K MT)
Figure 16. Active Pharmaceutical Ingredient (API) Consumed in Rheumatology
Figure 17. Global Active Pharmaceutical Ingredient (API) Market: Rheumatology (2018-2023) & (K MT)
Figure 18. Active Pharmaceutical Ingredient (API) Consumed in Diabetes
Figure 19. Global Active Pharmaceutical Ingredient (API) Market: Diabetes (2018-2023) & (K MT)
Figure 20. Active Pharmaceutical Ingredient (API) Consumed in Oncology
Figure 21. Global Active Pharmaceutical Ingredient (API) Market: Oncology (2018-2023) & (K MT)
Figure 22. Active Pharmaceutical Ingredient (API) Consumed in Others
Figure 23. Global Active Pharmaceutical Ingredient (API) Market: Others (2018-2023) & (K MT)
Figure 24. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2022)
Figure 25. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Application in 2022
Figure 26. Active Pharmaceutical Ingredient (API) Sales Market by Company in 2022 (K MT)
Figure 27. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Company in 2022
Figure 28. Active Pharmaceutical Ingredient (API) Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Company in 2022
Figure 30. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Active Pharmaceutical Ingredient (API) Sales 2018-2023 (K MT)
Figure 33. Americas Active Pharmaceutical Ingredient (API) Revenue 2018-2023 ($ Millions)
Figure 34. APAC Active Pharmaceutical Ingredient (API) Sales 2018-2023 (K MT)
Figure 35. APAC Active Pharmaceutical Ingredient (API) Revenue 2018-2023 ($ Millions)
Figure 36. Europe Active Pharmaceutical Ingredient (API) Sales 2018-2023 (K MT)
Figure 37. Europe Active Pharmaceutical Ingredient (API) Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales 2018-2023 (K MT)
Figure 39. Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue 2018-2023 ($ Millions)
Figure 40. Americas Active Pharmaceutical Ingredient (API) Sales Market Share by Country in 2022
Figure 41. Americas Active Pharmaceutical Ingredient (API) Revenue Market Share by Country in 2022
Figure 42. Americas Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2018-2023)
Figure 43. Americas Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2018-2023)
Figure 44. United States Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Active Pharmaceutical Ingredient (API) Sales Market Share by Region in 2022
Figure 49. APAC Active Pharmaceutical Ingredient (API) Revenue Market Share by Regions in 2022
Figure 50. APAC Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2018-2023)
Figure 51. APAC Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2018-2023)
Figure 52. China Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Active Pharmaceutical Ingredient (API) Sales Market Share by Country in 2022
Figure 60. Europe Active Pharmaceutical Ingredient (API) Revenue Market Share by Country in 2022
Figure 61. Europe Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2018-2023)
Figure 62. Europe Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2018-2023)
Figure 63. Germany Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2018-2023)
Figure 72. Egypt Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Active Pharmaceutical Ingredient (API) Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient (API) in 2022
Figure 78. Manufacturing Process Analysis of Active Pharmaceutical Ingredient (API)
Figure 79. Industry Chain Structure of Active Pharmaceutical Ingredient (API)
Figure 80. Channels of Distribution
Figure 81. Global Active Pharmaceutical Ingredient (API) Sales Market Forecast by Region (2024-2029)
Figure 82. Global Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の医薬品有効成分（API）市場予測 2023年-2029年(Global Active Pharmaceutical Ingredient (API) Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のセリシスタット（EX-527）市場予測 2023年-2029年
  • 世界の医薬品有効成分（API）市場予測2023年-2028年
  • 動物医薬品用フルララネルAPIの世界市場見通し2023年-2029年
  • 世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場予測 2023年-2029年
  • 世界のエチルセルロース（EC）市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆